Список литературы

Поставить закладку

Scully R.E., Young R.H., Clement P.B. Tumor like lesions. Tumors of the ovary and maldeveloped gonads, fallopian tube and broad ligament. Washington: Armed Forces Institute of Pathology, 1998. Pp. 443–444.
Shih I.M., Kurman R.J. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 2004;164(5):1511–8.
Shih I.M., Kurman R.J. Molecular pathogenesis of ovarian borderline tumors: new insights and old challenges. Clin Cancer Res 2005;11(20):7273–9.
Kempson R.L., Hendrickson M.R. Ovarian serous borderline tumors: the citadel defended. Hum Pathol 2000;31(5):525–6.
Acs G. Serous and mucinous borderline (low malignant potential) tumors of the ovary. Am J Clin Pathol 2005;123(Suppl.):13–57.
International Statistical Classification of Diseases and Related Health Problems. 10^th Revision.
WHO Classification of tumors. Female genital tumours 5^th edition, 2020Ayhan A., Akarin R., Develioglu O. et al. Borderline epithelial ovarian tumors. Aust N Z J Obstet Gynecol 1991;31(2):174–6.
Губина О.В. Особенности клинического течения и лечения пограничных опухолей яичников. Автореф. дис. … канд. мед. наук. М., 1995.
Ledermann J. A., Raja F. A., Fotopoulou C. et al. Newly Diagnosed and Relapsed Epithelial Ovarian Carcinoma: ESMO Clinical Practice Guidelines // Ann Oncol. – 2013. –V. 24 (Suppl 6). – P. vi24–vi32.
Давыдова И.Ю., Карселадзе А.И., Кузнецов В.В. и др. Практические рекомендации по лекарственному лечению пограничных опухолей яичников. Злокачественные опухоли: практические рекомендации RUSSCO, 2018 г. Т. 8. С. 171–177.
Ebell M.H., Culp M.B., Radke T.J. A systematic review of symptoms for the diagnosis of ovarian cancer. Am J Prev Med 2016;50(3):384–94.
NCCN guidelines panel. Epithelial ovarian cancer (including fallopian tube cancer and primary peritoneal cancer). Version 1.2016. Available at: https://www.nccn.org/professionals/physician_gls/f_guidelines.asp#ovarian.
Stiekema A., Boldingh Q.J., Korse C.M. et al. Serum human epididymal protein 4 (HE4) as biomarker for the differentiation between epithelial ovarian cancer and ovarian metastases of gastrointestinal origin. Gynecol Oncol 2015;136(3):562–6.
Santotoribio J.D., Garcia de la Torre A., Cañavate-Solano C. et al. Cancer antigens 19.9 and 125 as tumor markers in patients with mucinous ovarian tumors. Eur J Gynaecol Oncol 2016;37(1):26–9.
Morotti M. et al. The preoperative diagnosis of borderline ovarian tumors: a review of current literature //Archives of gynecology and obstetrics. – 2012. – Т. 285. – С. 1103-1112.
Lenhard M. et al. Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer //BMC cancer. – 2012. – Т. 12. – С. 1-8.
Ledermann J.A., Raja F.A., Fotopoulou C. et al. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines. Ann Oncol 2013;24(Suppl 6):vi24–32.
Levi F. et al. Second neoplasms after invasive and borderline ovarian cancer //European Journal of Cancer Prevention. – 2009. – Т. 18. – №. 3. – С. 216-219.
Trimbos J.B., Parmar M., Vergote I. et al. International collaborative ovarian neoplasm trial 1 and adjuvant chemotherapy in ovarian neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. J Natl Cancer Inst 2003;95(2):105–12.
Rooth C. Ovarian cancer: risk factors, treatment and management. Br J Nurs 2013;22(17):S23–30.
NCCN Guidelines Version 1.2019 Ovarian Borderline Epithelial Tumors. Available at: https://www.nccn.org/professionals/physician_gls/f_guidelines.asp#ovarian.
Vasconcelos I. Management of borderline ovarian tumors state of the art. Uterus & Ovary 2015;2:1–6. DOI: 10.14800/uo.885.
Vasconcelos I. Conservative surgery in ovarian borderline tumours: A meta-analysis with emphasis on recurrence risk. Eur J Cancer 2015;51(5):620–31.
Camatte S., Morice P., Thoury A. et al. Impact of surgical staging in patients with macroscopic “stage I” ovarian borderline tumours: analysis of a continuous series of 101 cases. Eur J Cancer 2004;40(12):1842–9.
Новикова Е.Г., Баталова Г.Ю. Пограничные опухоли яичников. М.: Медицинское информационное агентство, 2007. 152 с.
Trillsch F. Mahner S., Ruetzel J.D. et al. Clinical management of borderline ovarian tumors. Expert Rev Anticancer Ther 2010;10(7):1115–24.
Новикова Е.Г., Шевчук А.С., Завалишина Л.Э. Некоторые аспекты органосохраняющего лечения пограничных опухолей яичников. Российский онкологический журнал 2010;(4):15–20.
Ushijima K., Kawano K., Tsuda N. et al. Epithelial borderline ovarian tumor: Diagnosis and treatment strategy. Obstet Gynecol Sci 2015;58(3):183–7.
Kleppe М., Bruls J., van Gorp T. et al. Mucinous borderline tumours of the ovary and the appendix: a retrospective study and overview of the literature Gynecol. Oncol 2014;133(2):155–8.
Morice P., Camatte S., Wicart-Poque F. et al. Results of conservative management of epithelial malignant and borderline ovarian tumours. Hum Reprod 2003;9(2):185–92.
Карселадзе А.И. К морфологии муцинозных пограничных опухолей яичников. Архив патологии 1989;51(5):40–6.
Du Bois A., Ewald-Riegler N., du Bois O., Harter P. Borderline tumors of the ovary: a systematic review. Geburtsh Frauenheilk 2009;69:807–33.
Абузарова Г.Р., Арутюнов Г.П. Хронический болевой синдром (ХБС) у взрослых пациентов, нуждающихся в паллиативной медицинской помощи. Клинические рекомендации, 2018 г.
Silver J.K., Baima J. Cancer prehabilitation: an opportunity to decrease treatment- related morbidity, increase cancer treatment options, and improve physical and psychological health outcomes. Am J Phys Med Rehabil 2013;92(8):715–27.
Nilsson H., Angeras U., Bock D., Börjesson M., Onerup A., Fagevik Olsen M., Gellerstedt M., Haglind E., Angenete E. Is preoperative physical activity related to post-surgery recovery? BMJ Open. 2016 Jan 14;6(1):e007997. doi: 10.1136/bmjopen-2015-007997.
Tsimopoulou I., Pasquali S., Howard R., Desai A., Gourevitch D., Tolosa I., Vohra R. Psychological Prehabilitation Before Cancer Surgery: A Systematic Review. Ann Surg Oncol. 2015 Dec;22(13):4117-23. doi: 10.1245/s10434-015-4550-z. Epub 2015 Apr 14.
Nelson G., Bakkum-Gamez J., Kalogera E. et al Guidelines for perioperative care in gynecologic/oncology: Enhanced Recovery After Surgery (ERAS) Society recommendations – 2019 update International Journal of Gynecologic Cancer Published Online First: 15 March 2019. doi: 10.1136/ijgc-2019-000356.
Wren S.M., Martin M., Yoon J.K., Bech F. Postoperative pneumonia-prevention program for the inpatient surgical ward // Journal of the American College of Surgeons. – 2010. –Vol. 210, No. 4 – pp. 491–495.
Goerling U., Jaeger C., Walz A. et al. The efficacy of psycho-oncological interventions for women with gynaecological cancer: A randomized study // Oncology. 2014;87:114–124. Crossref, Medline.
Shehadeh A., El Dahleh M., Salem A. et al. Standardization of rehabilitation after limb salvage surgery for sarcomas improves patients’ outcome. Hematol Oncol Stem Cell Ther 2013;6(3–4):105–11.
Marchese V.G., Spearing E., Callaway L. et al. Relationships among range of motion, functional mobility, and quality of life in children and adolescents after limb-sparing surgery for lower-extremity sarcoma. Pediatr Phys Ther 2006;18(4):238–44.
Cox C.L., Montgomery M., Oeffinger K.C. et al. Promoting physical activity in childhood cancer survivors: results from the Childhood Cancer Survivor Study. Cancer 2009;115(3):642–54.
Tinelli F., Tinelli R., La Grotta F. et al. Pregnancy outcome and recurrence after conservative laparoscopic surgery for borderline ovarian tumors. Acta Obstet Gynecol Scand 2007;86(1):81–7.
Mooney J., Silva E., Tornos C. et al. Unusual features of serous neoplasms of low malignant potential during pregnancy. Gynecol Oncol 1997;65(1):30–5.
Kaern J., Tropé C.G., Abeler V.M. A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982. A review of clinicopathologic features and treatment modalities. Cancer 1993;71(5):1810–20.
Morice P., Camatte S., Wicart-Poque F. et al. Results of conservative management of epithelial malignant and borderline ovarian tumours. Hum Reprod Update 2003;9(2):185–92.
Fischerova D. et al. Ultrasound in preoperative assessment of pelvic and abdominal spread in patients with ovarian cancer: a prospective study //Ultrasound in Obstetrics & Gynecology. – 2017. – Т. 49. – №. 2. – С. 263-274.
Oken M.M., Creech R.H., Tormey D.C. et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982,5(6):649–55.
Karnofsky DA, Burchenal JH: The clinical evaluation of chemotherapeutic agents in cancer. In: Evaluation of chemotherapeutic agents. edn. Edited by MacLeod C. New York: Columbia University Press; 1949: 191-205
Т.А. Назаренко, А.Г. Бурдули, Я.О. Мартиросян, Л.Г. Джанашвили Криоконсервация репродуктивного материала у онкологических больных. Акушерство и Гинекология N9/2019, С.40-48
C. Rousset-Jablonski et al. Gynecol. Obstet.. Fertil. Senol. 2020 Mar.
Sahin F. et al. Borderline ovarian tumors: twenty years of experience at a tertiary center //Anatolian Current Medical Journal. – 2023. – Т. 5. – №. 3. – С. 196-200.
Diniz G. et al. Expression of human epididymal secretory protein 4 may be a predictor for invasiveness in ovarian epithelial tumors //Eur. J. Gynaecol. Oncol. – Т. 38. – №. 6. – С. 2017.
Minar L. et al. Comparison of the Copenhagen Index versus ROMA for the preoperative assessment of women with ovarian tumors //International Journal of Gynecology & Obstetrics. – 2018. – Т. 140. – №. 2. – С. 241-246.
Robertson D. M. et al. Inhibins and ovarian cancer //Molecular and cellular endocrinology. – 2004. – Т. 225. – №. 1-2. – С. 65-71.
Matsas A. et al. Tumor markers and their diagnostic significance in ovarian cancer //Life. – 2023. – Т. 13. – №. 8. – С. 1689.
Carbonnel M. et al. Serous borderline ovarian tumor diagnosis, management and fertility preservation in young women //Journal of Clinical Medicine. – 2021. – Т. 10. – №. 18. – С. 4233.
Park J. Y. et al. Surgical management of borderline ovarian tumors: the role of fertility-sparing surgery //Gynecologic oncology. – 2009. – Т. 113. – №. 1. – С. 75-82.
Chen R. et al. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience //Journal of Ovarian Research. – 2016. – Т. 9. – С. 1-8.
Tal O. et al. Characteristics and prognosis of borderline ovarian tumors in pre and postmenopausal patients //Archives of Gynecology and Obstetrics. – 2020. – Т. 302. – С. 693-698.
Raimondo D. et al. The impact of hysterectomy on oncological outcomes in postmenopausal patients with borderline ovarian tumors: A multicenter retrospective study //Frontiers in Oncology. – 2022. – Т. 12. – С. 1009341